0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-1.04
Negative P/E while CRN.AX shows 1.35. Joel Greenblatt would examine path to profitability versus competitor.
0.27
P/S less than half of CRN.AX's 1.42. Joel Greenblatt would verify if margins support this discount.
-1.22
Negative equity while CRN.AX shows P/B of 1.02. Joel Greenblatt would examine balance sheet repair potential.
6.38
P/FCF 1.25-1.5x CRN.AX's 4.28. Martin Whitman would scrutinize if premium reflects better growth prospects.
2.54
P/OCF 50-75% of CRN.AX's 4.06. Bruce Berkowitz would examine if working capital management explains the gap.
-1.22
Negative fair value while CRN.AX shows ratio of 1.02. Joel Greenblatt would examine valuation model differences.
-24.14%
Negative earnings while CRN.AX shows yield of 18.48%. Joel Greenblatt would examine path to profitability.
15.66%
FCF yield 50-75% of CRN.AX's 23.35%. Martin Whitman would scrutinize if lower yield reflects better reinvestment.